Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3257071000168111 | Restylane (hyaluronic acid 20 mg / 1 mL) injection, 1 x 1 mL syringe (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3257081000168114 | Restylane 20 mg/mL injection, 1 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Restylane 20 mg/mL injection, 1 mL syringe | Is a | Restylane 20 mg/mL injection, 1 mL syringe | true | Inferred relationship | Some | ||
| Restylane 20 mg/mL injection, 1 mL syringe | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Restylane 20 mg/mL injection, 1 mL syringe | has TPUU | Restylane 20 mg/mL injection, syringe | true | Inferred relationship | Some | 1 | |
| Restylane 20 mg/mL injection, 1 mL syringe | has container type | syringe | true | Inferred relationship | Some | ||
| Restylane 20 mg/mL injection, 1 mL syringe | has TP | Restylane | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR